Transcripts
Phathom Pharmaceuticals (PHAT) earnings call transcripts
Earnings call transcripts for Phathom Pharmaceuticals, Inc., with a summary, the guidance given, and what analysts pressed on.
FreeSee Phathom Pharmaceuticals' financials in GloomOpen in browser →- Q3 2026 earnings call
Management framed the quarter as evidence that access initiatives are beginning to support growth while the company sustains profitability and funds GI expansion plans.
Oct 29, 2026Positive0.68 - Q2 2026 earnings call
Management framed the quarter as proof of its GI-first pivot, while identifying prescription-access friction as the main near-term constraint on broader growth.
Jul 30, 2026Positive0.55